Updated:
Vertex Ventures HC
Vertex Ventures HC deploys $500M across biotech, medtech, and digital health. It operates inside Vertex's global venture network.
Vertex Ventures HC
Vertex Ventures HC sits inside Vertex Holdings, a global venture network with affiliates across China, Israel, Japan, Southeast Asia, India, and the US. The healthcare-dedicated fund operates from San Francisco and Singapore, building a concentrated portfolio of biotech, medical device, and digital health companies. The firm reports $500 million under management and more than 25 portfolio companies that have collectively achieved FDA-cleared products and multiple clinical-stage assets. Notable exits include companies acquired by Merck, Alcon, Medtronic, and Otsuka. Strategy concentrates on early-stage through expansion-stage life sciences companies developing transformative therapies and medical technologies. The portfolio spans three verticals: biotech (17 companies), medtech (9 companies), and services. Vertex Ventures HC takes a hands-on approach, supporting companies through key growth and value-creation milestones. Confirmed positions include Boundless Bio, which develops ecDNA-directed therapies for aggressive gene-amplified cancers. Recent alliance activity includes Septerna's collaboration with Novo Nordisk on oral small-molecule programs and Bicycle Therapeutics' clinical updates on nuzefatide pevedotin. Vertex Ventures HC does not disclose its team size or individual leadership publicly. The firm lists a Singapore contact address at Raffles City Tower and routes communications through the parent entity's domain. In late-stage dealmaking, the firm has participated in transactions that produced multiple FDA-cleared products. No recent fund closes or personnel moves are verifiable from the firm's current public disclosures. The structural differentiator is its access to Vertex's global network of affiliated funds — a built-in cross-border diligence and co-investment layer across five continents. This architecture lets the healthcare fund share deal flow and intelligence with generalist and sector-specific teams in Asia and the Middle East, creating a sourcing and syndication advantage that standalone life sciences VCs do not typically have.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Additional offices
Singapore
Sector focus
Frequently asked questions
Who runs investment decisions at Vertex Ventures HC?
Vertex Ventures HC does not name its investment committee or managing partners on its public website. Inquiries route through the parent Vertex Holdings entity at a Singapore contact address. The leadership structure has not been disclosed publicly as of the latest firm filings.
How does Vertex Ventures HC source proprietary deal flow?
The firm leverages Vertex's global network of affiliate funds in China, Israel, Japan, Southeast Asia, India, and the US. This multi-continent architecture provides visibility into academic spinouts, regulatory-proximate opportunities, and cross-border syndication channels that a standalone US healthcare fund would not typically access.
What investment stages does Vertex Ventures HC typically target?
Vertex Ventures HC invests from seed and startup stage through late-stage growth, per the firm's stated strategy. Portfolio support is structured around key value-creation milestones including clinical advancement and FDA clearance, indicating active engagement from early development through regulatory approval and exit.
Does Vertex Ventures HC participate in fund commitments or only direct deals?
Vertex Ventures HC primarily makes direct investments in therapeutics, medical device, and digital health companies. The firm does not publicly describe a fund-of-funds allocation or LP commitment program. Its model centers on building and managing a concentrated portfolio of operating companies.
How is Vertex Ventures HC related to the broader Vertex Holdings network?
Vertex Ventures HC is one of several venture capital funds in the Vertex global network, alongside affiliates in China, Israel, Japan, Southeast Asia, and India. Each affiliate operates in a specific geography or sector, sharing the Vertex brand and, in some cases, co-investment channels. The healthcare fund's communications domain routes through the Vertex Holdings parent.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: